
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Naltrexone
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : JanOne
Deal Size : $30.0 million
Deal Type : Acquisition
JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC
Details : Jan123 (naltrexone) is being developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 10, 2023
Lead Product(s) : Naltrexone
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : JanOne
Deal Size : $30.0 million
Deal Type : Acquisition
